Roundtable: Focus on FL | Blood Cancers Today
Watch exclusive roundtable discussions focused on important news and updates in follicular lymphoma on Blood Cancers Today.
Related Articles
Statin Use Associated With Improved Survival in Patients With CLL/SLL Treated With Ibrutinib | Blood Cancers Today
A pooled analysis of the RESONATE, RESONATE-2, iLLUMINATE, and HELIOS trials found that statin use was associated with improved overall survival and progression-free survival.
LucyRx Expands Specialty Pharmacy Network to Remove Barriers in Cancer Care | Blood Cancers Today
LucyRx’s pharmacy network includes Northwestern Medicine Specialty Pharmacy, Dana Farber Cancer Institute, City of Hope, and more.
Is Relative PFS Performance of Belantamab Mafodotin Adequately Reflected in MM Clinical Trials? | Blood Cancers Today
Investigators assert clinical trial design features may have contributed to this antibody-drug conjugate’s loss of approvals.
The HemOnc Pulse Live | Blood Cancers Today
The second annual HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 2-3 in Austin, Texas.
CD19 CAR-T Therapy Offers Safe and, Effective Approach for Transformed Indolent Lymphomas | Blood Cancers Today
Charles Gaulin, MBBS, of Dartmouth Geisel School of Medicine, discussed the safety and efficacy of CD19 CAR-T cell therapy for patients with transformed indolent lymphoma.
The HemOnc Pulse Live | Blood Cancers Today
The second annual HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 2-3 in Austin, Texas.
Novel Immunotherapeutic Strategy May Advance Treatment for AML, MDS | Blood Cancers Today
Neoantigen-based T-cell receptor T-cell therapies are emerging as effective, antitumor treatments for patients with myeloid leukemia.
Blazing a Trail in Ph-ALL: Chemotherapy-Free Options Gain Ground | Blood Cancers Today
The pillars of recent success in the treatment of ALL include a better breakdown of high-risk subgroups and the introduction of novel therapies.
The HemOnc Pulse Live | Blood Cancers Today
The second annual HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 2-3 in Austin, Texas.
Advancing the Frontiers of Myelodysplastic Syndromes | Blood Cancers Today
Andrew Brunner, MD, discusses the latest advancements in the understanding and management of myelodysplastic syndromes, including molecular profiling and ongoing clinical trials.